These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1610419)

  • 1. Comparative pharmacokinetics and bioavailability study of percutaneous absorption of diclofenac from two topical formulations containing drug as a solution gel or as an emulsion gel.
    Seth BL
    Arzneimittelforschung; 1992 Feb; 42(2):120-2. PubMed ID: 1610419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous absorption of ibuprofen from different formulations. Comparative study with gel, hydrophilic ointment and emulsion cream.
    Seth PL
    Arzneimittelforschung; 1993 Aug; 43(8):919-21. PubMed ID: 8216453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation].
    Scheidel B; Blume H; Walter K; von Nieciecki A; Babej-Dölle RM
    Arzneimittelforschung; 1993 Nov; 43(11):1211-5. PubMed ID: 8292067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Favourable dermal penetration of diclofenac after administration to the skin using a novel spray gel formulation.
    Brunner M; Dehghanyar P; Seigfried B; Martin W; Menke G; Müller M
    Br J Clin Pharmacol; 2005 Nov; 60(5):573-7. PubMed ID: 16236050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers.
    Kienzler JL; Gold M; Nollevaux F
    J Clin Pharmacol; 2010 Jan; 50(1):50-61. PubMed ID: 19841157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The bioavailability of enteric coated diclofenac formulations. 2. Bioavailability following single administration of a multiple-unit formulation in comparison to a single-unit formulation under fasting and non-fasting conditions].
    Scheidel B; Blume H; Walter K; Stanislaus F; Babej-Dölle RM
    Arzneimittelforschung; 1994 Apr; 44(4):544-50. PubMed ID: 8011009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the formulation on the in vitro transdermal penetration of sodium diclofenac. Evaluation of the topical and systemic anti-inflammatory activity in the rat.
    Calpena AC; Escribano E; San Martin H; Lauroba J; Obach R; Domenech J
    Arzneimittelforschung; 1999 Dec; 49(12):1012-7. PubMed ID: 10635447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and bioavailability of percutaneous ibuprofen.
    Kleinbloesem CH; Ouwerkerk M; Spitznagel W; Wilkinson FE; Kaiser RR
    Arzneimittelforschung; 1995 Oct; 45(10):1117-21. PubMed ID: 8595072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lecithin on epicutaneous absorption of diclofenac epolamine.
    Conte A; Ronca G; Petrini M; Mautone G
    Drugs Exp Clin Res; 2002; 28(6):249-55. PubMed ID: 12776579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and drug input characteristics for a diclofenac-codeine phosphate combination following oral and rectal administration.
    Hanses A; Spahn-Langguth H; Meiss F; Mutschler E
    Arzneimittelforschung; 1996 Jan; 46(1):57-63. PubMed ID: 8821519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative bioavailability of two suspension formulations of potassium diclofenac in healthy male volunteers.
    Mendes GB; Franco LM; Moreno RA; Fernandes AG; Muscara MN; de Nucci G
    Int J Clin Pharmacol Ther; 1994 Mar; 32(3):131-5. PubMed ID: 8205374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetic analysis of a novel sustained-release dosage form of diclofenac sodium in healthy subjects.
    Raz I; Hussein Z; Samara E; Ben-David J
    Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):246-8. PubMed ID: 3410601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose pharmacokinetic study of rapidly dispersing diclofenac potassium formulations in healthy volunteers.
    Lissy M; Stiff DD; Kowalski MM; Moore KA
    Curr Med Res Opin; 2009 Oct; 25(10):2423-8. PubMed ID: 19663688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics and biological availability of diclofenac preparations following intramuscular injection of 75 mg and oral administration of 150 mg of active drug].
    Kurowski M
    Z Rheumatol; 1988; 47(1):37-42. PubMed ID: 3369245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative bioavailability of a dispersible formulation of diclofenac and finding of double plasma peaks.
    Macía MA; Frias J; Carcas AJ; Guerra P; Valiente R; Lucero ML
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):333-9. PubMed ID: 7582384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study on the relative bioavailability of a sustained-release formulation of diclofenac sodium.
    Suleiman MS; Najib N; el-Sayed Y; Hasan M; Abdulahameed M
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):276-9. PubMed ID: 2737796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical diclofenac: new preparation. Moderate efficacy in actinic keratosis.
    Prescrire Int; 2004 Aug; 13(72):138-9. PubMed ID: 15532138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence of diclofenac sodium 2% and 1.5% topical solutions relative to oral diclofenac sodium in healthy volunteers.
    Holt RJ; Taiwo T; Kent JD
    Postgrad Med; 2015 Aug; 127(6):581-90. PubMed ID: 26077436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative bioavailability and pharmacokinetics of Dolotren retard and Dolotren].
    Honorato J; Montes B; Suárez J; Lucero ML; Valiente R
    Rev Med Univ Navarra; 1992; 37(1):7-16. PubMed ID: 1626168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.